{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:48:31Z","timestamp":1794469711447,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":91,"publisher":"Springer New York","isbn-type":[{"value":"9781493903252","type":"print"},{"value":"9781493903269","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-4939-0326-9_1","type":"book-chapter","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T08:01:58Z","timestamp":1391500918000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pathology of Systemic Lupus Erythematosus: The Challenges Ahead"],"prefix":"10.1007","author":[{"given":"Pedro Correia","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grainne","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Isenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/0961203309350755","volume":"19","author":"LJ Lu","year":"2010","unstructured":"Lu LJ, Wallace DJ, Ishimori ML, Scofield RH, Weisman MH (2010) Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus 19:119\u2013129","journal-title":"Lupus"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/art.1780380415","volume":"38","author":"AE Johnson","year":"1995","unstructured":"Johnson AE, Gordon C, Palmer RG, Bacon PA (1995) The prevalence and incidence of systemic lupus erythematosus in Birmingham, England: relationship to ethnicity and county of birth. Arthritis Rheum 38:551\u2013558","journal-title":"Arthritis Rheum"},{"key":"1_CR3","first-page":"1333","volume-title":"Dubois\u2019 Lupus erythematosus","author":"DD Gladman","year":"2007","unstructured":"Gladman DD, Urowitz MB (2007) Prognosis, mortality and morbidity in systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois\u2019 Lupus erythematosus, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1333\u20131353","edition":"7"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0889-857X(05)70137-X","volume":"26","author":"KE Sullivan","year":"2000","unstructured":"Sullivan KE (2000) Genetic of systemic lupus erythematosus: clinical implications. Rheum Dis Clin North AM 26:229\u2013256","journal-title":"Rheum Dis Clin North AM"},{"issue":"Suppl 3","key":"1_CR5","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1186\/ar586","volume":"4","author":"MJ Walport","year":"2002","unstructured":"Walport MJ (2002) Complement and systemic lupus erythematosus. Arthritis Res 4(Suppl 3):S279\u2013S293","journal-title":"Arthritis Res"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1086\/518257","volume":"80","author":"Y Yang","year":"2007","unstructured":"Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B et al (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Geneti 80:1037\u20131054","journal-title":"Am J Hum Geneti"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.ejhg.5201827","volume":"15","author":"RR Graham","year":"2007","unstructured":"Graham RR, Ortmann W, Rodine P, Espe K, Langefeld C, Lange E et al (2007) Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 15:823\u2013830","journal-title":"Eur J Hum Genet"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg D (2008) Systemic lupus erythematosus. N Eng J Med 358:929\u2013939","journal-title":"N Eng J Med"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ng.81","volume":"40","author":"JB Harley","year":"2008","unstructured":"Harley JB, Alarc\u00f3n-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL et al (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40:204\u2013210","journal-title":"Nat Genet"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"RR Graham","year":"2006","unstructured":"Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW et al (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38:550\u2013555","journal-title":"Nat Genet"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/428480","volume":"76","author":"S Sigurdsson","year":"2005","unstructured":"Sigurdsson S, Nordmark G, Goring HHH, Lindroos K, Wiman AC, Sturfelt G et al (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5genes are associated with systemic lupus erythematosus. Am J Hum Gen 76:528\u2013537","journal-title":"Am J Hum Gen"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/art.1780200103","volume":"20","author":"R Stern","year":"1977","unstructured":"Stern R, Fishman J, Brusman H, Kunkel HG (1977) Systemic lupus erythematosus associated with Klinefelter\u2019s syndrome. Arthritis Rheum 20:18\u201322","journal-title":"Arthritis Rheum"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1186\/ar2759","volume":"11","author":"G Chanchoub","year":"2009","unstructured":"Chanchoub G, Uz E, Maalej A (2009) Analysis of skewed X chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis Res Ther 11:R106","journal-title":"Arthritis Res Ther"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.autrev.2011.08.003","volume":"11","author":"M Cutolo","year":"2011","unstructured":"Cutolo M, Pizzorni C, Sulli A (2011) Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev 11:84\u201387","journal-title":"Autoimmun Rev"},{"key":"1_CR16","doi-asserted-by":"crossref","unstructured":"Patel D, Richardson B (2013) Drug-induced lupus: etiology, pathogenesis, and clinical aspects. In: Wallace DJ, Hahn BH (eds) Dubois\u2019 Lupus erythematosus, 8th edn. Elsevier, Philadelphia, pp 484\u2013494","DOI":"10.1016\/B978-1-4377-1893-5.00039-X"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1172\/JCI119856","volume":"100","author":"JA James","year":"1997","unstructured":"James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100:3019\u20133026","journal-title":"J Clin Invest"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1001976","volume":"364","author":"MG Netea","year":"2001","unstructured":"Netea MG, van der Meer JWH (2001) Mechanisms of disease\u2014immunodeficiency and genetic defects of pattern-recognition receptors. N Eng J Med 364:60\u201370","journal-title":"N Eng J Med"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","volume":"115","author":"LE Ronnblom","year":"1991","unstructured":"Ronnblom LE, Alm GV, Oberg KE (1991) Autoimmunity after alpha-interferon therapy for malignant carcinoid-tumors. Ann Intern Med 115:178\u2013183","journal-title":"Ann Intern Med"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/art.1780221106","volume":"22","author":"RG Lahita","year":"1979","unstructured":"Lahita RG, Bradlow HL, Kunkel HG, Fishman J (1979) Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 22:1195\u20131198","journal-title":"Arthritis Rheum"},{"key":"1_CR21","first-page":"13","volume":"8","author":"JL Fromer","year":"1950","unstructured":"Fromer JL (1950) The use of testosterone in chronic lupus erythematosus. Preliminary report. Lahey Clin Bul 8:13\u201317","journal-title":"Lahey Clin Bul"},{"key":"1_CR22","first-page":"682","volume":"10","author":"V Agnello","year":"1983","unstructured":"Agnello V, Pariser K, Gell J, Gelfand J, Turksoy RN (1983) Preliminary observations on danazol therapy of systemic lupus erythematosus. Effects on DNA antibodies, thrombocytopaenia and complement. J Rheum 10:682\u2013687","journal-title":"J Rheum"},{"key":"1_CR23","first-page":"187","volume":"140","author":"M Zen","year":"2010","unstructured":"Zen M, Ghiradello A, Iaccarino L, Tonon M, Campana C, Arienti S et al (2010) Hormones, immune response and pregnancy in healthy women and pregnancy. Swiss Med Weekly 140:187\u2013201","journal-title":"Swiss Med Weekly"},{"key":"1_CR24","first-page":"67","volume":"305","author":"JF Cohen-Solal","year":"2006","unstructured":"Cohen-Solal JF, Jeganathan V, Grimaldi CM, Peeva E, Diamond B (2006) Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol 305:67\u201388","journal-title":"Curr Top Microbiol Immunol"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1172\/JCI0214873","volume":"109","author":"CM Grimaldi","year":"2002","unstructured":"Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B (2002) Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 109:1625\u20131633","journal-title":"J Clin Invest"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.180.3.1423","volume":"180","author":"MC Siracusa","year":"2008","unstructured":"Siracusa MC, Overstreet MG, Housseau F, Scott AL, Klein SL (2008) 17 beta-oestradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 180:1423\u20131431","journal-title":"J Immunol"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/08830189809042997","volume":"6","author":"T Hiran","year":"1998","unstructured":"Hiran T (1998) IL-6 and its receptor. Int Rev Immunol 6:249\u2013284","journal-title":"Int Rev Immunol"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1191\/0961203304lu1023oa","volume":"13","author":"E Tackey","year":"2004","unstructured":"Tackey E, Lipsky P, Illei G (2004) Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus 13:339\u2013343","journal-title":"Lupus"},{"key":"1_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.147.1.117","volume":"147","author":"M Linker-Israeli","year":"1991","unstructured":"Linker-Israeli M, Deans R, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus: a putative role in pathogenesis. J Immunol 147:117\u2013123","journal-title":"J Immunol"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000045663","volume":"85","author":"CY Tsai","year":"2000","unstructured":"Tsai CY, Wu TH, Yu CL, Lu JY, Tsai YY (2000) Increased excretions of \u03b22-microglobulin, IL-6 and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron 85:207\u2013214","journal-title":"Nephron"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-009-1226-8","volume":"28","author":"S Hirohata","year":"2009","unstructured":"Hirohata S, Kanai Y, Mitsuo A, Tokano Y, Hashimoto H (2009) Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicentre retrospective study. Clin Rheumatol 28:1319\u20131323","journal-title":"Clin Rheumatol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1191\/096120398678919949","volume":"7","author":"R Herrera-Esparza","year":"1998","unstructured":"Herrera-Esparza R, Barbosa-Cisneros R, Villalobos-Hurtado R, Avalos-Diaz E (1998) Renal expression of IL-6 and TNF-\u03b1 genes in lupus nephritis. Lupus 7:154\u2013158","journal-title":"Lupus"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1046\/j.1365-2249.1998.00612.x","volume":"112","author":"M Mihara","year":"1998","unstructured":"Mihara M, Takagi N, Takeda Y, Ohsugi Y (1998) IL-6 receptor blockade inhibits the onset of autoimmune kidney disease in NZB\/Wf1 mice. Clin Exp Immunol 112:397\u2013402","journal-title":"Clin Exp Immunol"},{"key":"1_CR34","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1002\/art.22257","volume":"54","author":"G Illei","year":"2006","unstructured":"Illei G, Yarboro C, Shirota Y, Daruwalla J, Tackey E, Takada K et al (2006) Tocilizumab (humanized anti-IL6 receptor antibody) in patients with systemic lupus erythematosus(SLE): safety, tolerability and preliminary efficacy. Arthritis Rheum 54:4043","journal-title":"Arthritis Rheum"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1084\/jem.181.3.839","volume":"181","author":"L Llorente","year":"1995","unstructured":"Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J et al (1995) Role of Interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181:839\u2013844","journal-title":"J Exp Med"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/rheumatology\/keg255","volume":"42","author":"WS Uhm","year":"2003","unstructured":"Uhm WS, Na K, Song GW, Jung SS, Lee T, Park MH et al (2003) Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford) 42:935\u2013938","journal-title":"Rheumatology (Oxford)"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/ard.62.1.37","volume":"62","author":"J Ronnelid","year":"2003","unstructured":"Ronnelid J, Tejde A, Mathsson L, Nilsson-Ekdahl K, Nilsson B (2003) Immune complexes from SLE sera induce IL-10 production from normal peripheral blood mononuclear cells by an Fc\u03b3RII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann Rheum Dis 62:37\u201342","journal-title":"Ann Rheum Dis"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1046\/j.1365-2567.2000.00970.x","volume":"99","author":"KH Sun","year":"2000","unstructured":"Sun KH, Yu CL, Tang SJ, Sun GH (2000) Monoclonal anti-double stranded DNA autoantibody stimulates the expression of IL-1\u03b2, IL-6, IL-8, IL-10 and TNF-\u03b1 from normal human mononuclear cells involving in the lupus pathogenesis. Immunology 99:352\u2013360","journal-title":"Immunology"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2","volume":"43","author":"L Llorente","year":"2000","unstructured":"Llorente L, Richaud-Patin Y, Garcia-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH et al (2000) Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43:1790\u20131800","journal-title":"Arthritis Rheum"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1191\/096120300674499064","volume":"9","author":"G Bengtsson","year":"2000","unstructured":"Bengtsson G, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H et al (2000) Activation of type 1 Interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9:664\u2013671","journal-title":"Lupus"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ et al (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100:2610\u20132615","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E","volume":"43","author":"Y Ioannou","year":"2000","unstructured":"Ioannou Y, Isenberg DA (2000) Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 43:1431\u20131442","journal-title":"Arthritis Rheum"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","volume":"19","author":"P Fitzgerald-Bocarsly","year":"2008","unstructured":"Fitzgerald-Bocarsly P, Dai J, Singh S (2008) Plasmacytoid dendritic cells and type 1 IFN: 50 years of convergent history. Cytokine Growth Factor Rev 19:3\u201319","journal-title":"Cytokine Growth Factor Rev"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/art.20254","volume":"50","author":"T Lovgren","year":"2004","unstructured":"Lovgren T, Eloranta ML, Bave U, Alm GV, R\u00f6nnblom L (2004) Induction of interferon-\u03b1 production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50:1861\u20131872","journal-title":"Arthritis Rheum"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nm1590","volume":"13","author":"R Baccala","year":"2007","unstructured":"Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos N (2007) TLR-dependent and TLR-independent pathways of Type 1 interferon induction in systemic autoimmunity. Nat Med 13:543\u2013551","journal-title":"Nat Med"},{"key":"1_CR46","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.4049\/jimmunol.176.4.2074","volume":"176","author":"A Le Bon","year":"2006","unstructured":"Le Bon A, Thompson C, Kamphuis E, Durand V, Rossmann C, Kalinke U et al (2006) Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type 1 IFN. J Immunol 176:2074\u20132078","journal-title":"J Immunol"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/art.23613","volume":"58","author":"TB Niewold","year":"2008","unstructured":"Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley B, Crow MK (2008) Association of the IRF5 risk haplotype with high serum interferon-\u03b1 activity in systemic lupus erythematosus patients. Arthritis Rheum 58:2481\u20132487","journal-title":"Arthritis Rheum"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa073003","volume":"357","author":"EF Remmers","year":"2007","unstructured":"Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW et al (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357:977\u2013986","journal-title":"N Engl J Med"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"365083","DOI":"10.1155\/2010\/365083. Epub 2010 May 6","volume":"2010","author":"D Hin Yap","year":"2010","unstructured":"Hin Yap D, Neng Lai K (2010) Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed 2010:365083. doi:10.1155\/2010\/365083. Epub 2010 May 6","journal-title":"J Biomed"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","volume":"127","author":"CK Wong","year":"2008","unstructured":"Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th-17 mediated inflammation in auto-immunity. Clin Immunol 127:385\u2013393","journal-title":"Clin Immunol"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","volume":"183","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Kyttaris VC, Tsokos GC (2009) The role of IL-23\/IL-17 axis in lupus nephritis. Journal Immunol 183:3160\u20133169","journal-title":"Journal Immunol"},{"key":"1_CR52","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crispin","year":"2008","unstructured":"Crispin JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE et al (2008) Expanded double-negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. Journal Immunol 181:8761\u20138766","journal-title":"Journal Immunol"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay F, Schneider P (2009) Cracking the BAFF code. Nat Rev Immunol 9:491\u2013502","journal-title":"Nat Rev Immunol"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1182\/blood.V97.1.198","volume":"97","author":"B Nardelli","year":"2001","unstructured":"Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS et al (2001) Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:198\u2013204","journal-title":"Blood"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1126\/science.1061964","volume":"293","author":"PA Moore","year":"2001","unstructured":"Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P et al (2001) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 293:2111\u20132114","journal-title":"Science"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","volume":"44","author":"GS Cheema","year":"2001","unstructured":"Cheema GS, Roschke V, Hilbert DM, Stohl W (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44:1313\u20131319","journal-title":"Arthritis Rheum"},{"issue":"9767","key":"1_CR57","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","volume":"377","author":"SV Navarra","year":"2011","unstructured":"Navarra SV, Guzm\u00e1n RM, Gallacher AE, Hall S, Levy RA, Jimenez RE et al (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377(9767):721\u2013731","journal-title":"Lancet"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/331356a0","volume":"331","author":"CO Jacob","year":"1988","unstructured":"Jacob CO, Mcdevitt HO (1988) Tumour necrosis factor-alpha in murine autoimmune lupus nephritis. Nature 331:356\u2013358","journal-title":"Nature"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0140-6736(02)09800-8","volume":"360","author":"AK Mohan","year":"2002","unstructured":"Mohan AK, Edwards ET, Cote TR, Siegal JN, Braun MM (2002) Drug-induced systemic lupus erythematosus and TNF-alpha blockers. Lancet 360:646","journal-title":"Lancet"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1002\/art.20576","volume":"50","author":"M Aringer","year":"2004","unstructured":"Aringer M, Graninger WB, Steiner G, Smolen JS (2004) Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open label study. Arthritis Rheum 50:3161\u20133169","journal-title":"Arthritis Rheum"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<339::AID-IMMU339>3.0.CO;2-C","volume":"28","author":"CT Ravirajan","year":"1998","unstructured":"Ravirajan CT, Rahman MA, Papadaki L, Griffiths MH, Kalsi J, Martin AC et al (1998) Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis. Eur J Immunol 28:339\u2013350, Erratum: Eur J Immunol 1999; 29: 3052","journal-title":"Eur J Immunol"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/ard.52.1.14","volume":"52","author":"M Okamura","year":"1993","unstructured":"Okamura M, Kanayama Y, Amastu K, Negoro N, Kohda S, Takeda T et al (1993) Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann Rheum Dis 52:14\u201320","journal-title":"Ann Rheum Dis"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/rheumatology\/keh354","volume":"43","author":"A Rahman","year":"2004","unstructured":"Rahman A (2004) Autoantibodies, lupus and the science of sabotage. Rheumatology (Oxford) 43:1326\u20131336","journal-title":"Rheumatology (Oxford)"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1172\/JCI6801","volume":"104","author":"L Lu","year":"1999","unstructured":"Lu L, Kaliyaperumal A, Boumpas DT, Datta SK (1999) Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J Clin Invest 104:345\u2013355","journal-title":"J Clin Invest"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10875-010-9504-4","volume":"31","author":"HK Kang","year":"2011","unstructured":"Kang HK, Chiang MY, Liu M, Ecklund D, Datta SK (2011) The histone peptide H471-94 is more effective than a cocktail of peptides epitopes in controlling lupus: immunoregulatory mechanisms. J Clin Immunol 31:379\u2013394","journal-title":"J Clin Immunol"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1089\/jir.2011.0029","volume":"31","author":"SA Apostolidis","year":"2011","unstructured":"Apostolidis SA, Lieberman LA, Kis-Toth K, Crispin JC, Tsokos GC (2011) The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res 31:769\u2013779","journal-title":"J Interferon Cytokine Res"},{"key":"1_CR67","first-page":"15","volume":"15","author":"A Gigante","year":"2011","unstructured":"Gigante A, Gasperini ML, Afeltra A, Barbano B, Margiotta D, Cianci R et al (2011) Cytokines expression in SLE nephritis. Eur Rev Med Pharmacol Sci 15:15\u201324","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"e1002341","DOI":"10.1371\/journal.pgen.1002341","volume":"7","author":"DS Cunninghame Graham","year":"2011","unstructured":"Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syv\u00e4nen AC, R\u00f6nnblom L et al (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 7:e1002341","journal-title":"PLoS Genet"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/ard.2007.075424","volume":"67","author":"AH Sawalha","year":"2008","unstructured":"Sawalha AH, Kaufman KM, Kelly JA, Adler AJ, Aberle T, Kilpatrick J et al (2008) Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 67:458\u2013461","journal-title":"Ann Rheum Dis"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775\u2013787","journal-title":"Cell"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2889","volume":"10","author":"JH Buckner","year":"2010","unstructured":"Buckner JH (2010) Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10:849\u2013859","journal-title":"Nat Rev Immunol"},{"key":"1_CR72","unstructured":"Yurasov SV, Wardermann H, Hammersen J, Pascual V, Meffre E, Nussenzweig MC (2004) Autoreactive B cells and immune tolerance alterations in peripheral blood of patients with systemic autoimmunity. Pediatr Res 292A"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","volume":"113","author":"T Alexander","year":"2009","unstructured":"Alexander T, Thiel A, Rosen O, Massenkeil G, Sattler A, Kohler S et al (2009) Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induced long term remission through de novo generation of a juvenile and tolerant immune system. Blood 113:214\u2013223","journal-title":"Blood"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0065-2776(07)96005-8","volume":"96","author":"F Nimmerjahn","year":"2007","unstructured":"Nimmerjahn F, Ravetch JV (2007) Fc-receptors as regulators of immunity. Adv Immunol 96:179\u2013204","journal-title":"Adv Immunol"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood.V99.6.2154","volume":"99","author":"F Medina","year":"2002","unstructured":"Medina F, Segundo C, Campos-Caro A, Gonz\u00e1lez-Garc\u00eda I, Brieva JA (2002) The heterogeneity shown by human plasma cells from tonsil, blood and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99:2154\u20132161","journal-title":"Blood"},{"key":"1_CR76","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","volume":"165","author":"M Odendahl","year":"2000","unstructured":"Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR et al (2000) Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 165:5970\u20135979","journal-title":"J Immunol"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.berh.2005.05.006","volume":"19","author":"JH Anolik","year":"2005","unstructured":"Anolik JH, Aringer M (2005) New treatments for SLE: cell-depleting and anti-cytokine therapies. Best Pract Res Clin Rheumatol 19:859\u2013878","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1_CR78","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.468","volume":"41","author":"V Gateva","year":"2009","unstructured":"Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X et al (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41:1228\u20131233","journal-title":"Nat Genet"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR et al (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32:129\u2013140","journal-title":"Immunity"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","volume":"36","author":"A Bosma","year":"2012","unstructured":"Bosma A, Abel-Gadir A, Isenberg DA, Jury EC, Mauri C (2012) Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36:477\u2013490","journal-title":"Immunity"},{"key":"1_CR81","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1084\/jem.126.4.607","volume":"126","author":"D Koffler","year":"1967","unstructured":"Koffler D, Schur PH, Kunkel HG (1967) Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 126:607\u2013624","journal-title":"J Exp Med"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/art.1780280907","volume":"28","author":"DA Isenberg","year":"1985","unstructured":"Isenberg DA, Shoenfeld Y, Walport M, Mackworth-Young C, Dudeney C, Todd-Pokropek A et al (1985) Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum 28:999\u20131007","journal-title":"Arthritis Rheum"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/art.22356","volume":"55","author":"KP Ng","year":"2006","unstructured":"Ng KP, Manson JJ, Rahman A, Isenberg DA (2006) Association of anti-nucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum 55:900\u2013904","journal-title":"Arthritis Rheum"},{"key":"1_CR84","first-page":"1495","volume":"30","author":"M Mannik","year":"2003","unstructured":"Mannik M, Merrill CE, Stamps LD, Wener MH (2003) Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 30:1495\u20131504","journal-title":"J Rheumatol"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","volume":"97","author":"RD Sontheimer","year":"1982","unstructured":"Sontheimer RD, Maddison PJ, Reichlin M, Jordan RE, Stastny P, Gilliam JN (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97:664\u2013671","journal-title":"Ann Intern Med"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"19854","DOI":"10.1073\/pnas.0608397104","volume":"103","author":"C Kowal","year":"2006","unstructured":"Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT et al (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 103:19854\u201319859","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR87","first-page":"527","volume-title":"Dubois\u2019 Lupus erythematosus","author":"FP Quisimoro","year":"2007","unstructured":"Quisimoro FP (2007) Other serologic abnormalities in systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois\u2019 Lupus erythematosus, 7th edn. Lippincott Williams and Wilkins, Philadelphia, pp 527\u2013550","edition":"7"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2141.1995.tb08919.x","volume":"89","author":"M Pujol","year":"1995","unstructured":"Pujol M, Ribera A, Vildarell M, Ordi J, Feliu E (1995) High prevalence of platelet auto-antibodies in patients with systemic lupus erythematosus. Br J Haematol 89:137\u2013141","journal-title":"Br J Haematol"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00041552-199905000-00005","volume":"8","author":"JH Berden","year":"1999","unstructured":"Berden JH, Licht R, van Bruggen MC, Tax WJ (1999) Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr Opin Nephrol Hypertens 8:299\u2013306","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1_CR90","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.ki.5002133","volume":"71","author":"M Kalaaji","year":"2007","unstructured":"Kalaaji M, Fenton KA, Mortensen ES, Olsen R, Sturfelt G, Alm P et al (2007) Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 71:664\u2013672","journal-title":"Kidney Int"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2353\/ajpath.2006.051329","volume":"168","author":"M Kalaaji","year":"2006","unstructured":"Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP (2006) Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 168:1779\u20131792","journal-title":"Am J Pathol"}],"container-title":["Methods in Molecular Biology","Systemic Lupus Erythematosus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-0326-9_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T06:14:11Z","timestamp":1706163251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-0326-9_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9781493903252","9781493903269"],"references-count":91,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-0326-9_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-0326-9","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"22 January 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}